semaglutide home injections Weight Management for Adults with Obesity Ozempic® & Wegovy® Weight-Loss Injections

Important topics include: Potential drug interactions between GLP-1 medications and DMARDs Monitoring strategies for both conditions Whether weight loss might improve RA symptoms or treatment response Cardiovascular risk reduction strategies Safety considerations including contraindications (personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Patients should not discontinue or modify DMARD therapy based on unproven theories about GLP-1 medications treating RA

Timeline: High-dose results won't be available until 2028+, well after standard-dose approval

"It's about the size of a small city," says David Ricks, Eli Lilly's CEO

doi:10.3410/b1-63

,

Generally, no special preparation is needed